Ethoxzolamide
From Wikipedia, the free encyclopedia
Image:Ethoxzolamide.png | |
Ethoxzolamide
|
|
Systematic (IUPAC) name | |
6-ethoxybenzothiazole-2-sulfonamide | |
Identifiers | |
CAS number | 452-35-7 |
ATC code | ? |
PubChem | 3295 |
DrugBank | APRD00732 |
Chemical data | |
Formula | C9H10N2O3S2 |
Mol. weight | 258.319 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Protein binding | ~89% |
Metabolism | ? |
Half life | 2.5-5.5 hours |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Ethoxzolamide (alternatively known as Ethoxyzolamide) is a sulfonamide medication that functions as a carbonic anhydrase inhibitor. It is used in the treatment of glaucoma, duodenal ulcers, and as a diuretic. It may also be used in the treatment of some forms of epilepsy.
Brand names include Cardrase®, Diuretic C®, Ethamide®, Glaucotensil®, and Redupresin®.